Lanean...
Metabolite profiling in retinoblastoma identifies novel clinicopathological subgroups
BACKGROUND: Tumour classification, based on histopathology or molecular pathology, is of value to predict tumour behaviour and to select appropriate treatment. In retinoblastoma, pathology information is not available at diagnosis and only exists for enucleated tumours. Alternative methods of tumour...
Gorde:
| Argitaratua izan da: | Br J Cancer |
|---|---|
| Egile Nagusiak: | , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Nature Publishing Group
2015
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4647873/ https://ncbi.nlm.nih.gov/pubmed/26348444 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2015.318 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|